Capstone Investment Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.49M | Buy |
38,100
+26,900
| +240% | +$2.35M | 0.01% | 585 |
|
|
2026
Q1 | $955K | Buy |
11,200
+3,700
| +49% | +$330K | ﹤0.01% | 876 |
|
|
2025
Q4 | $593K | Sell |
7,500
-5,700
| -43% | -$447K | ﹤0.01% | 1086 |
|
|
2025
Q3 | $1.06M | Buy |
13,200
+8,000
| +154% | +$682K | ﹤0.01% | 996 |
|
|
2025
Q2 | $473K | Sell |
5,200
-18,500
| -78% | -$1.69M | ﹤0.01% | 1169 |
|
|
2025
Q1 | $2.22M | Sell |
23,700
-30,000
| -56% | -$2.69M | 0.01% | 655 |
|
|
2024
Q4 | $4.88M | Buy |
53,700
+11,000
| +26% | +$1.05M | 0.01% | 549 |
|
|
2024
Q3 | $4.43M | Buy |
42,700
+1,400
| +3% | +$143K | 0.01% | 493 |
|
|
2024
Q2 | $4.01M | Buy |
41,300
+4,100
| +11% | +$378K | 0.01% | 507 |
|
|
2024
Q1 | $3.35M | Sell |
37,200
-16,200
| -30% | -$1.37M | 0.01% | 583 |
|
|
2023
Q4 | $4.26M | Buy |
53,400
+32,300
| +153% | +$2.43M | 0.01% | 590 |
|
|
2023
Q3 | $1.5M | Sell |
21,100
-1,700
| -7% | -$127K | 0.01% | 832 |
|
|
2023
Q2 | $1.76M | Buy |
22,800
+1,100
| +5% | +$85.1K | 0.01% | 684 |
|
|
2023
Q1 | $1.63M | Buy |
21,700
+6,100
| +39% | +$454K | 0.01% | 647 |
|
|
2022
Q4 | $1.23M | Buy |
15,600
+2,500
| +19% | +$187K | 0.01% | 864 |
|
|
2022
Q3 | $920K | Sell |
13,100
-900
| -6% | -$70.6K | 0.01% | 1064 |
|
|
2022
Q2 | $1.12M | Sell |
14,000
-59,400
| -81% | -$4.64M | 0.01% | 964 |
|
|
2022
Q1 | $5.57M | Sell |
73,400
-65,900
| -47% | -$5.22M | 0.02% | 664 |
|
|
2021
Q4 | $11.9M | Sell |
139,300
-20,500
| -13% | -$1.6M | 0.02% | 554 |
|
|
2021
Q3 | $12.1M | Buy |
159,800
+36,000
| +29% | +$2.86M | 0.02% | 558 |
|
|
2021
Q2 | $10.1M | Buy |
123,800
+3,800
| +3% | +$311K | 0.02% | 533 |
|
|
2021
Q1 | $9.46M | Buy |
120,000
+4,100
| +4% | +$321K | 0.03% | 476 |
|
|
2020
Q4 | $9.91M | Buy |
115,900
+31,300
| +37% | +$2.59M | 0.03% | 406 |
|
|
2020
Q3 | $6.53M | Buy |
84,600
+27,800
| +49% | +$2.12M | 0.03% | 442 |
|
|
2020
Q2 | $4.16M | Buy |
56,800
+16,000
| +39% | +$1.14M | 0.03% | 489 |
|
|
2020
Q1 | $2.71M | Sell |
40,800
-46,100
| -53% | -$3.25M | 0.04% | 431 |
|
|
2019
Q4 | $5.98M | Buy |
86,900
+400
| +0.5% | +$27.3K | 0.03% | 499 |
|
|
2019
Q3 | $6.36M | Buy |
86,500
+32,100
| +59% | +$2.33M | 0.04% | 383 |
|
|
2019
Q2 | $3.9M | Buy |
54,400
+16,500
| +44% | +$1.17M | 0.03% | 530 |
|
|
2019
Q1 | $2.6M | Buy |
37,900
+11,800
| +45% | +$762K | 0.02% | 512 |
|
|
2018
Q4 | $1.55M | Buy |
26,100
+11,100
| +74% | +$694K | 0.02% | 502 |
|
|
2018
Q3 | $1M | Buy |
+15,000
| New | +$999K | 0.01% | 592 |
|
|
2017
Q1 | – | Sell |
-4,000
| Closed | -$261K | – | 906 |
|
|
2016
Q4 | $261K | Buy |
+4,000
| New | +$274K | 0.01% | 764 |
|
|
2016
Q1 | – | Sell |
-309,200
| Closed | -$20.6M | – | 658 |
|
|
2015
Q4 | $20.6M | Buy |
309,200
+239,200
| +342% | +$15.9M | 0.55% | 41 |
|
|
2015
Q3 | $4.44M | Buy |
70,000
+6,200
| +10% | +$405K | 0.1% | 145 |
|
|
2015
Q2 | $4.17M | Sell |
63,800
-21,100
| -25% | -$1.43M | 0.06% | 183 |
|
|
2015
Q1 | $5.89M | Buy |
84,900
+27,200
| +47% | +$1.88M | 0.1% | 137 |
|
|
2014
Q4 | $3.99M | Sell |
57,700
-62,000
| -52% | -$4.19M | 0.06% | 182 |
|
|
2014
Q3 | $7.81M | Buy |
+119,700
| New | +$7.89M | 0.09% | 180 |
|
|
2014
Q2 | – | Sell |
-70,000
| Closed | -$4.54M | – | 410 |
|
|
2014
Q1 | $4.54M | Hold |
70,000
| – | – | 0.06% | 172 |
|
|
2013
Q4 | $4.56M | Hold |
70,000
| – | – | 0.05% | 214 |
|
|
2013
Q3 | $4.15M | Buy |
+70,000
| New | +$4.15M | 0.04% | 227 |
|
Other funds holding CL
Capstone Investment Advisors's CL Position: Q2 2026 in Review
Capstone Investment Advisors reduced its Colgate-Palmolive (CL) stake by 95% in Q2 2026, selling an estimated $13.8M and leaving 7,805 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.
Capstone Investment Advisors first reported a position in CL in Q2 2014 and has held it in 33 quarters since. The position peaked at $16.6M in Q4 2014. 2,027 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Capstone Investment Advisors held 7,805 shares of Colgate-Palmolive worth $716K as of Q2 2026.
- Capstone Investment Advisors sold 157,270 Colgate-Palmolive shares in Q2 2026, an estimated $13.8M.
- Colgate-Palmolive made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1080 holding.
- Capstone Investment Advisors first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 33 quarters since.
- Capstone Investment Advisors's Colgate-Palmolive position peaked at $16.6M in Q4 2014.
- 2,027 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.